학술논문

1035P A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)
Document Type
Abstract
Source
In Annals of Oncology September 2022 33 Supplement 7:S1028-S1029
Subject
Language
ISSN
0923-7534